Redcare Pharmacy valuation
€67.60Change from previous close: −3.77%Absolute change: −€2.65
Valuation
The average price target of 10 analysts is €87.60.
Data as of October 4, 2026
Valuation multiples
- Market cap
- €1.41B
- Enterprise value
- €1.7B
- Forward P/E
- 56.5
- Price/book
- 3.16
- Price/sales
- 0.44
- EV/EBITDA
- 90.4
- EV/revenue
- 0.53
Profitability and growth
- Gross margin
- 21.6%
- Operating margin
- 1.4%
- Net margin
- -1.3%
- ROE
- -8.7%
- ROA
- -0.2%
- Revenue growth (year over year)
- 20.3%
- Earnings growth (year over year)
- -50.4%
Financial health
- Total cash
- €118.9M
- Total debt
- €354.7M
- Debt/equity
- 0.75
- Current ratio
- 1.59
- Quick ratio
- 0.78
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- €87.60
- Median price target
- €89.50
- High price target
- €116.00
- Low price target
- €55.00
- Analysts with a price target
- 10
- Consensus
- Buy
- Forward EPS
- €1.24
- EPS estimate, current year
- -€0.36
Shares and trading
- Beta
- 1.42
- Average volume
- 85.38K
- Shares outstanding
- 20.11M
- Float
- 19.65M
- Institutional ownership
- 37.9%
- Insider ownership
- 18.7%